Teva, Glenmark To Pay $305M In Latest DOJ Generics Deal

By Bryan Koenig · August 21, 2023, 5:01 PM EDT

The U.S. Department of Justice announced its largest settlement to date Monday in ongoing price-fixing enforcement against major generic-drug companies, with Teva set to pay a $225 million criminal penalty and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

USA v. GLENMARK PHARMACEUTICALS, INC., USA

Case Number

2:20-cr-00200

Court

Pennsylvania Eastern

Nature of Suit

Date Filed

June 30, 2020